Literature DB >> 11518689

Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

A Burich1, R Hershberg, K Waggie, W Zeng, T Brabb, G Westrich, J L Viney, L Maggio-Price.   

Abstract

Inflammatory bowel disease (IBD) is thought to result from a dysregulated mucosal immune response to luminal microbial antigens, with T lymphocytes mediating the colonic pathology. Infection with Helicobacter spp has been reported to cause IBD in immunodeficient mice, some of which lack T lymphocytes. To further understand the role of T cells and microbial antigens in triggering IBD, we infected interleukin (IL)-10(-/-), recombinase-activating gene (Rag)1(-/-), T-cell receptor (TCR)-alpha(-/-), TCR-beta(-/-), and wild-type mice with Helicobacter hepaticus or Helicobacter bilis and compared the histopathological IBD phenotype. IL-10(-/-) mice developed severe diffuse IBD with either H. bilis or H. hepaticus, whereas Rag1(-/-), TCR-alpha(-/-), TCR-beta(-/-), and wild-type mice showed different susceptibilities to Helicobacter spp infection. Proinflammatory cytokine mRNA expression was increased in the colons of Helicobacter-infected IL-10(-/-) and TCR-alpha(-/-) mice with IBD. These results confirm and extend the role of Helicobacter as a useful tool for investigating microbial-induced IBD and show the importance, but not strict dependence, of T cells in the development of bacterial-induced IBD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518689     DOI: 10.1152/ajpgi.2001.281.3.G764

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  86 in total

1.  Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice.

Authors:  K A Eaton; J S Opp; B M Gray; I L Bergin; V B Young
Journal:  Vet Pathol       Date:  2010-10-06       Impact factor: 2.221

2.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease.

Authors:  Ulrich R M Bohr; Bernhard Glasbrenner; Anett Primus; Alexandra Zagoura; Thomas Wex; Peter Malfertheiner
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.

Authors:  Katharine H Banner; Christophe Cattaneo; Jean-Loic Le Net; Aleksandar Popovic; David Collins; Jeremy D Gale
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

Review 5.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 6.  The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.

Authors:  Christopher A Lowry; David G Smith; Philip H Siebler; Dominic Schmidt; Christopher E Stamper; James E Hassell; Paula S Yamashita; James H Fox; Stefan O Reber; Lisa A Brenner; Andrew J Hoisington; Teodor T Postolache; Kerry A Kinney; Dante Marciani; Mark Hernandez; Sian M J Hemmings; Stefanie Malan-Muller; Kenneth P Wright; Rob Knight; Charles L Raison; Graham A W Rook
Journal:  Curr Environ Health Rep       Date:  2016-09

7.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

8.  Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD.

Authors:  Y Zeng; J Stokes; S Hahn; E Hoffman; E Katsanis
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

9.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

Review 10.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.